PharmaCyte Biotech Inc Tangible Net Worth Ratio
PharmaCyte Biotech Inc tangible net worth ratio. PharmaCyte Biotech Inc (PMCB) has a Tangible Net Worth Ratio of 100.0% as of April 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($34.98 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check PharmaCyte Biotech Inc (PMCB) strategic investment index to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of PharmaCyte Biotech Inc (2006–2026)
Tangible net worth ratio of PharmaCyte Biotech Inc from 2006 to 2026. This chart shows how PharmaCyte Biotech Inc's Tangible Net Worth Ratio has changed across 17 annual periods from 2006 to 2026. As of April 2026, the ratio stands at 100.0%, reflecting net assets of $34.98 Million with intangible assets of $0.00 USD. See PharmaCyte Biotech Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
PharmaCyte Biotech Inc Tangible Net Worth Ratio by Year (2006–2026)
PharmaCyte Biotech Inc tangible net worth ratio by year from 2006 to 2026. The table below presents the year-by-year Tangible Net Worth Ratio for PharmaCyte Biotech Inc from 2006 to 2026, covering 17 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see how much is PharmaCyte Biotech Inc worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 100.0% | $34.98 Million | $0.00 | $46.75 Million | ▲ +3.0 pp |
| 2025 | 97.0% | $51.89 Million | $1.55 Million | $55.17 Million | ▲ +0.9 pp |
| 2024 | 96.1% | $39.51 Million | $1.55 Million | $59.90 Million | ▲ +1.0 pp |
| 2023 | 95.1% | $72.69 Million | $3.55 Million | $73.28 Million | ▼ -0.9 pp |
| 2022 | 96.1% | $89.92 Million | $3.55 Million | $90.62 Million | ▲ +49.2 pp |
| 2021 | 46.9% | $6.68 Million | $3.55 Million | $7.40 Million | ▲ +16.6 pp |
| 2020 | 30.3% | $5.09 Million | $3.55 Million | $6.17 Million | ▲ +0.7 pp |
| 2019 | 29.6% | $5.04 Million | $3.55 Million | $5.78 Million | ▼ -8.9 pp |
| 2018 | 38.5% | $5.77 Million | $3.55 Million | $6.41 Million | ▼ -17.6 pp |
| 2017 | 56.1% | $8.09 Million | $3.55 Million | $8.67 Million | ▲ +10.5 pp |
| 2016 | 45.6% | $6.52 Million | $3.55 Million | $7.16 Million | ▲ +5.4 pp |
| 2015 | 40.2% | $5.94 Million | $3.55 Million | $7.95 Million | ▼ -20.1 pp |
| 2014 | 60.3% | $8.94 Million | $3.55 Million | $9.32 Million | ▼ -34.1 pp |
| 2009 | 94.4% | $3.12 Million | $174.04K | $6.04 Million | ▲ +6.0 pp |
| 2008 | 88.4% | $7.44 Million | $863.40K | $7.62 Million | ▲ +8.5 pp |
| 2007 | 79.8% | $4.29 Million | $863.87K | $4.41 Million | ▼ -20.2 pp |
| 2006 | 100.0% | $4.41 Million | $0.00 | $5.14 Million | — |